Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Top Cited Papers
Open Access
- 22 October 2013
- journal article
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 227
- https://doi.org/10.1186/1741-7015-11-227
Abstract
Australia was one of the first countries to introduce a publicly funded national human papillomavirus (HPV) vaccination program that commenced in April 2007, using the quadrivalent HPV vaccine targeting 12- to 13-year-old girls on an ongoing basis. Two-year catch-up programs were offered to 14- to 17- year-old girls in schools and 18- to 26-year-old women in community-based settings. We present data from the school-based program on population-level vaccine effectiveness against cervical abnormalities in Victoria, Australia.Keywords
This publication has 26 references indexed in Scilit:
- Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancerInternational Journal of Cancer, 2012
- Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, AustraliaSexual Health, 2011
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia Grade 3Cancer Epidemiology, Biomarkers & Prevention, 2010
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young WomenJNCI Journal of the National Cancer Institute, 2010
- Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 yearsThe Lancet, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPublished by Elsevier ,2009
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialThe Lancet, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical CancerCancer Epidemiology, Biomarkers & Prevention, 2005